logo

For the Inventor, By the Inventor

Pawcatuck, CT, United States of America

Michael J Castaldi

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 36(Granted Patents)


Location History:

  • Pawcatuk, CT (US) (1999)
  • Pawcatuck, CT (US) (2000 - 2007)

Company Filing History:

goldMedal11 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1999-2007

Loading Chart...
11 patents (USPTO):Explore Patents
1. 7183414 - Processes for the preparation of benzoimidazole derivatives (2007-02-27),
2. 7038061 - Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-(2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl)-ethylpyrrolidine (2006-05-02),
3. 6846930 - Heterocyclo-alkylsulfonyl pyrazole derivatives (2005-01-25),
4. 6646128 - Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives (2003-11-11),
5. 6444826 - Processes and intermediates for preparing substituted chromanol derivatives (2002-09-03),
6. 6355825 - Processes and intermediates for preparing substituted chromanol derivatives (2002-03-12),
7. 6316632 - Process for preparing 2-phenyl-3-aminopyridine, substituted phenyl derivatives, thereof, and salts thereof (2001-11-13),
8. 6288242 - Processes and intermediates for preparing substituted chromanol derivatives (2001-09-11),
9. 6255320 - Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions (2001-07-03),
10. 6096906 - Processes for preparing substituted chromanol derivatives (2000-08-01),
11. 5939550 - Process for preparing derivatives of azabicyclo naphthyridine carboxylic (1999-08-17),

Title: Michael J Castaldi: Innovator in Pharmaceutical Chemistry

Introduction

Michael J Castaldi is a prominent inventor based in Pawcatuck, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work primarily focuses on the development of innovative processes for the preparation of various pharmaceutical compounds.

Latest Patents

Among his latest patents, Castaldi has developed processes for the preparation of benzoimidazole derivatives. This invention relates to a method for preparing a compound that is useful in the treatment of abnormal cell growth, such as cancer, in mammals. Another notable patent involves crystalline anhydrous and monohydrate benzoate salts of a specific compound. These benzoate salts and their pharmaceutical compositions serve as selective kappa-receptor agonists, which are beneficial as analgesics, anesthetics, anti-inflammatory agents, or in the treatment of conditions such as arthritis, stroke, or functional bowel disease.

Career Highlights

Michael J Castaldi is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Castaldi has collaborated with notable colleagues, including Anthony D Piscopio and Joel Michael Hawkins. These collaborations have further enhanced the impact of his inventions in the field.

Conclusion

Michael J Castaldi's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of various medical conditions. His contributions continue to shape the future of medicine and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…